AMICUS THERAPEUTICS, INC. — Director's Dealing 2016

Nov 10, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-11-09

Reporting Person: Quimi Daphne (SVP, Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-09	Common stock	S	5688	$8.00	Disposed	24189	Direct
2016-11-09	Common stock	M	2858	$8.00	Acquired	27047	Direct
2016-11-09	Common stock	S	2858	$8.00	Disposed	24189	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-09	Stock Options (right to buy)	$2.45	M	2858	Disposed	2024-01-03	Common stock (2858)	Direct

Footnotes

F1: The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2016.

F2: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2016.